XML 78 R61.htm IDEA: XBRL DOCUMENT v3.25.3
Investment in Cyclo Therapeutics, Llc. (Details) - USD ($)
12 Months Ended
Dec. 23, 2024
Oct. 20, 2023
Aug. 01, 2023
May 02, 2023
Feb. 09, 2023
Nov. 15, 2021
Feb. 03, 2020
Jul. 31, 2025
Jul. 31, 2024
Mar. 25, 2025
Sep. 01, 2021
Mar. 31, 2021
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Realized gain (in Dollars)               $ 178,000 $ 1,772,000      
Outstanding principal and accrued interest (in Dollars) $ 2,500,000             $ 30,600,000        
Cyclo common stock (in Shares) 3,968,254                 12,998,194    
Unrealized gains (in Dollars)                 $ 37,000      
Percentage of issued and outstanding shares             12.00%          
Price per share (in Dollars per share)               $ 0.005   $ 0.72    
Ownership interests               37.50%        
Line of Credit Agreement [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Amount of revolving commitment to funds (in Dollars)             $ 50,000,000          
Investment in Cyclo Therapeutics, Inc. [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Issuance of common shares (in Shares)     4,000,000 2,514,970                
Purchase of warrants (in Shares)   2,514,970 4,000,000 2,514,970                
Exercise price (in Dollars per share)   $ 0.71 $ 1.25 $ 0.71                
Aggregate purchase price (in Dollars)     $ 5,000,000 $ 2,100,000                
Unrealized loss (in Dollars)               $ 5,100,000        
Investment in Cyclo Therapeutics, Inc. [Member] | May Warrant [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Exercise price (in Dollars per share)       $ 0.835                
Investment in Cyclo Therapeutics, Inc. [Member] | Replacement Warrant [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Purchase of warrants (in Shares)   2,766,467                    
Exercise price (in Dollars per share)   $ 0.95                    
Investment in Cyclo Therapeutics, Inc. [Member] | Warrant [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Ownership percentage   49.00%                    
Realized gain (in Dollars)   $ 424,000                    
Cornerstone [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Receivable balance due (in Dollars)               $ 720,000        
Percentage of issued and outstanding shares               12.00%        
Diluted capital stock               10.00%        
Fully diluted capital stock               10.00%        
Percentage of issued and outstanding equity               51.00%        
Cornerstone [Member] | Line of Credit Agreement [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Loan from line of credit agreement (in Dollars)               $ 25,000,000        
Payment to fund RP finance line of credit (in Dollars)               $ 21,900,000        
Lipomedix Pharmaceuticals Ltd. [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Financing principal amount (in Dollars)                       $ 400,000
Purchase of ordinary shares (in Shares)         70,000,000 15,975,000   15,975,000        
Price per share (in Dollars per share)         $ 0.03              
Purchase price (in Dollars)         $ 2,100,000 $ 3,000,000   $ 3,000,000        
Principal amount outstanding (in Dollars)                       400,000
Accrued interest (in Dollars)                       $ 21,800
Cash payment (in Dollars)               $ 2,600,000        
Investment owned percentage         95.00%     84.00%        
Noncontrolling interest (in Dollars)         $ 16,000     $ 8,000        
Lipomedix Pharmaceuticals Ltd. [Member] | Warrant [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Purchase of ordinary shares (in Shares)           15,975,000            
Price per share (in Dollars per share)           $ 0.1878            
RP Finance, LLC [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Ownership percentage               37.50%        
Common Stock [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Shares issued (in Shares)               6,067,306        
Other Stockholders [Member] | RP Finance, LLC [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Ownership percentage               25.00%        
Share Purchase Agreement [Member] | Lipomedix Pharmaceuticals Ltd. [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Investment owned percentage         5.00%              
Rafael Holdings Inc [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Ownership shares increased (in Shares) 12,998,194             12,998,194        
Rafael Holdings Inc [Member] | Investment in Cyclo Therapeutics, Inc. [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Ownership percentage 39.50%                      
Rafael Holdings Inc [Member] | Lipomedix Pharmaceuticals Ltd. [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Noncontrolling interest percentage               16.00%        
Loan [Member] | Cornerstone [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Accrued interest (in Dollars)               $ 25,000,000        
2023 Promissory Note [Member] | Cornerstone [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Cumulative total (in Dollars)               $ 2,000,000        
Interest rate               7.50%        
RPF Line of Credit [Member] | Cornerstone [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Ownership percentage               37.50%        
Amount of revolving commitment to funds (in Dollars)               $ 50,000,000        
Percentage of funding request required               37.50%        
Post-Reverse Stock Split [Member] | Cornerstone [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Stock split (in Shares)               261,230        
Post-Reverse Stock Split [Member] | Common Stock [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Shares issued (in Shares)             261,230          
Investment, Identifier [Axis]: Lipomedix Pharmaceuticals Ltd. [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Maturity date           Nov. 11, 2022         Sep. 01, 2021 Sep. 01, 2021
Interest rate                     15.00% 8.00%
Pharma Holdings [Member] | Cornerstone [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Ownership percentage               50.00%        
Percentage of owned non-operating subsidiary               90.00%        
Percentage of owned subsidiary               43.00%        
Pharma Holdings [Member] | Rafael Holdings Inc [Member] | Cornerstone [Member] | Howard Jonas [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Ownership percentage               10.00%        
CS Pharma Holdings [Member] | Cornerstone [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Ownership percentage               90.00%        
Percentage of owned non-operating subsidiary               50.00%        
Indirect interest               45.00%        
Percentage of issued and outstanding equity               8.00%        
Minimum [Member] | RPF Line of Credit [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Cumulative total (in Dollars)               $ 21,900,000        
Maximum [Member] | RPF Line of Credit [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Cumulative total (in Dollars)               $ 9,375,000        
Series D Preferred Stock [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Shares issued (in Shares)               60,673,087        
Series D Preferred Stock [Member] | Pharma Holdings [Member] | Cornerstone [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Preferred stock (in Dollars)               $ 44,000,000        
Series D Preferred Stock [Member] | CS Pharma Holdings [Member] | Cornerstone [Member]                        
Investment In Cyclo Therapeutics, LLC [Line Items]                        
Preferred stock (in Dollars)               $ 16,700,000